TradeLink Capital’s AbbVie ABBV Stock Holding History

TradeLink Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,800	Closed	-$480K	–	3
2024 Q2	$480K	Buy	+2,800	New	+$464K	1.38%	25
2023 Q3	–	Sell	-1,600	Closed	-$216K	–	3
2023 Q2	$216K	Buy	+1,600	New	+$235K	6.66%	9
2015 Q3	–	Sell	-3,107	Closed	-$209K	–	101
2015 Q2	$209K	Buy	+3,107	New	+$203K	0.31%	113
2015 Q1	–	Sell	-3,867	Closed	-$253K	–	109
2014 Q4	$253K	Sell	3,867 -214	-5%	-$13.5K	0.34%	82
2014 Q3	$235K	Hold	4,081	–	–	0.38%	61
2014 Q2	$229K	Buy	+4,081	New	+$214K	0.21%	129
2013 Q4	–	Sell	-600	Closed	-$27K	–	174
2013 Q3	$27K	Sell	600 -9,100	-94%	-$403K	0.06%	216
2013 Q2	$401K	Buy	+9,700	New	+$424K	0.12%	131

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

TradeLink Capital's ABBV Position: Q3 2024 in Review

TradeLink Capital sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 2,800 shares — an estimated $480K sold.

TradeLink Capital first reported a position in ABBV in Q2 2013 and held it in 8 quarters. The position peaked at $480K in Q2 2024. 3,504 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

TradeLink Capital reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
TradeLink Capital sold 2,800 AbbVie shares in Q3 2024, an estimated $480K.
TradeLink Capital first reported a position in AbbVie in Q2 2013 and held it in 8 quarters.
TradeLink Capital's AbbVie position peaked at $480K in Q2 2024.
3,504 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on TradeLink Capital's 13F filing for Q3 2024, filed 12 Nov 2024.